F About
FinalDose is developing a programmable DNA-targeting drug: a single smart molecule that, given a guide for a disease-causing genetic sequence, recognizes target DNA and triggers a cell kill-switch, aiming to address previously 'undruggable' cancer targets such as MYC, TP53, and APC. Founded 2025 in London by three Oxford PhDs (Jeff Liu, Li-Yao Huang, Steven Lin); Y Combinator-backed.
Focus Areas
Technology Focus
drug discovery scientific ai
Key People 3
- Jeff Liu
- Li-Yao Huang
- Steven Lin
Quick Stats
- Founded
- 2025
- Status
- private
- Type
- startup
Explore More
Similar Companies
Ranked by shared focus areas, technology, and location.
EvolutionaryScale
New York, United States
85%
1 shared category
2 shared AI types
Drug Discovery
Lila Sciences
San Francisco, United States
85%
1 shared category
2 shared AI types
Drug Discovery
Cradle
Amsterdam, Netherlands
85%
1 shared category
2 shared AI types
Drug Discovery
Aqemia
Paris, France
85%
1 shared category
2 shared AI types
Drug Discovery